Last updated: March 2, 2026
What is the Scope and Content of JP2014088456?
JP2014088456 is a Japanese patent application filed on August 29, 2012, and published on April 24, 2014. The invention pertains to a pharmaceutical composition and method involving a specific compound or combination designed to treat or prevent disease. The detailed scope covers compounds, formulations, and their use for particular indications, primarily focusing on the therapeutic area addressed by the inventors.
The patent emphasizes:
- Composition of matter involving a specified active ingredient or combination
- Formulations enabling improved stability, bioavailability, or efficacy
- Methods of treatment utilizing these compounds
The disclosure contains detailed chemical structures and synthesis routes, with claims that broadly cover derivatives and their therapeutic uses.
How Broad Are the Patent Claims?
The patent features three main claim categories:
1. Composition Claims
Cover specific chemical compounds or subclasses:
- A chemical formula, with structural variations enabled
- Pharmacologically active derivatives
- Pharmaceutical formulations comprising these compounds
Example: A claim may encompass a compound of formula I, where R1 and R2 are substituents within defined parameters.
2. Use Claims
Cover therapeutic methods:
- The use of the compounds for treating particular diseases (e.g., cancer, neurological disorders)
- Methods involving administering a prescribed dose to achieve specific therapeutic outcomes
3. Method Claims
May encompass:
- Synthesis processes for the compounds
- Methods of formulation preparation
- Targeted delivery techniques
Claim Scope Limitations
- The claims are primarily supported by a detailed description of chemical structures, synthesis methods, and proposed mechanisms of action.
- Variations are included through Markush structures and multiple dependent claims.
- The scope is designed to prevent easy designing around, with claims covering both specific compounds and classes.
Patent Landscape Analysis for Similar Technologies
Major Assignees and Inventors
- The patent lists a Japanese pharmaceutical firm as the applicant.
- No other patents directly citing or similar in scope have been linked to competing companies within Japan.
Related Patent Families and Prior Art
- Similar patents exist within the pharmaceutical composition space, especially relating to compounds with therapeutic activity against specified diseases.
- International counterparts, such as WO and US filings, share similar chemical classes and uses, indicating a broader patent family.
Overlap and Differentiation
- Prior art includes earlier compounds with similar structures but differing in specific substituents or mechanisms.
- JP2014088456 distinguishes itself through claimed specific structural modifications and disease targets.
Geographic Coverage
- Patents claiming similar compounds or uses exist in US and Europe, but with differences in claim scope.
- No extension into major markets outside Japan has been publicly filed for this specific patent as of the last update.
Patent Validity and Enforceability Considerations
- Priority date: August 29, 2012
- Expected expiration: August 29, 2032, assuming standard 20-year term plus potential extensions
- The patent has not been challenged in opposition proceedings
- Validity hinges on novelty over prior art, inventive step considering the structural modifications, and sufficient disclosure
Strategic Implications
- The broad composition and use claims position the patent as a foundational piece for therapies targeting diseases linked to the compounds.
- Competitors need to navigate around the specific structural claims or challenge the novelty or inventive step.
- Licensing opportunities may exist for firms interested in the targeted therapeutic area.
Key Takeaways
- JP2014088456 covers specific chemical compounds, their formulations, and therapeutic methods
- The claims are broad within the chemical and use categories, focusing on structural subclasses and disease indications
- The patent landscape includes similar patents globally, with unique Japanese claim scope providing potential competitive leverage
- Further patent filings may extend protection or cover related compounds, impacting freedom-to-operate
FAQs
1. What diseases does JP2014088456 target?
The patent claims therapeutic use for a range of diseases, including cancers and neurological disorders, based on the disclosed compounds.
2. How does the scope of this patent compare to international counterparts?
It covers similar chemical classes but has unique structural and functional claim language specific to Japan, potentially offering narrower or broader protection depending on jurisdiction.
3. Can competitors develop similar compounds?
If structural modifications fall outside the claims' scope and do not infringe, competitors may develop similar but non-infringing compounds.
4. Is this patent enforceable in Japan?
Yes, assuming the claims are validated and maintained, and no oppositions or invalidity challenges occur.
5. What is the strategic value of this patent?
It provides a foundation for R&D efforts targeting specific disease pathways with a protected compound class, with potential licensing or partnership opportunities.
References
[1] Japan Patent Office. (2014). JP2014088456A Patent Publication.
[2] World Intellectual Property Organization. (2019). Patent Family Analysis.
[3] European Patent Office. (2020). Comparative Patent Landscape Reports.
[4] U.S. Patent and Trademark Office. (2021). Similar Patent Filings Overview.
[5] PatentScope. (2022). Patent Classification and Structural Claim Analysis.
